IL-6 stimulates lncRNA ZEB2-AS1 to aggravate the progression of non-small cell lung cancer through activating STAT1.
Sign Up to like & getrecommendations! Published in 2020 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202004_20837
Abstract: OBJECTIVE To illustrate the role of interleukin 6 (IL-6) in the progression of non-small cell lung cancer (NSCLC) via activating STAT1. PATIENTS AND METHODS The level of IL-6 mRNA in 48 paired NSCLC tissues and… read more here.
Keywords: zeb2 as1; progression; a549 cells; activating stat1 ... See more keywords